The c.-1639g>A polymorphism of the VKORC1 gene and his influence on the therapeutic response during oral anticoagulants use
Background/Aim. A single nucleotide polymorphism c.- 1639G>A in the promoter region of vitamin K-epoxide reductase (VKORC1) gene has been found to account for most of the variability in response to oral anticoagulants (OA). The aim of the study was to determine the incidence and the effect of...
Main Authors: | Kovač Mirjana, Rakićević Ljiljana, Maslać Aleksandar, Radojković Dragica |
---|---|
Format: | Article |
Language: | English |
Published: |
Military Health Department, Ministry of Defance, Serbia
2009-01-01
|
Series: | Vojnosanitetski Pregled |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2009/0042-84500908617K.pdf |
Similar Items
-
The VKORC1 and CYP2C9 gene variants as pharmacogenetic factors in acenocoumarol therapy in Serbian patients - consideration of hypersensitivity and resistance
by: Rakićević Ljiljana, et al.
Published: (2022-01-01) -
Vkorc1 gene polymorphisms confer resistance to anticoagulant rodenticide in Turkish rats
by: Nuri Yiğit, et al.
Published: (2023-05-01) -
Investigation of the current status of anticoagulant resistance in UK Norway rats by VKORC1 genotyping
by: Clarke, D. J., et al.
Published: (2011-10-01) -
VKORC1 gene polymorphism (-1639G>A) in warfarin therapy patients of Pakistani population
by: Muhammad Bilal Ghafoor, et al.
Published: (2022-02-01) -
Polymorphisms of CYP2C9*2, CYP2C9*3 and VKORC1 genes related to time in therapeutic range in patients with atrial fibrillation using warfarin
by: Silveira MMBM, et al.
Published: (2019-08-01)